Growth hormone-insulin-like growth factor-I axis in adult insulin- dependent diabetic patients: Evidence for central hypersensitivity to growth hormone - Releasing hormone and peripheral resistance to growth hormone

Hormone and Metabolic Research

Volumn 30, Issue 12, 1998, Pages 737-742

  Day, Patricia Fainstein ^b   Fagin, J A ^a   Vaglio, R Mileo ^c   Litwak, L E ^c   Picasso, M F Russo ^c   Gutman, R A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (Argentina)

^c NONE

Author keywords

Growth Hormone; Insulin dependent diabetes; Insulin like growth factor 1; Insulin like growth factor binding protein 3

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; FEMALE; HORMONAL REGULATION; HORMONE DEPENDENCE; HORMONE RECEPTOR INTERACTION; HORMONE SENSITIVITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY;

EID: 0032408184     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978969     Document Type: Article

References (50)

1. Hansen AP. Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest 1970; 39: 1467-78
2. Hayford JT, Danney MM, Hendrix JA, Thompson RG. Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 1980; 29: 391-8
3. Molnar GD, Taylor WF, Langworthy A, Fatourechi V. Diurnal growth hormone and glucose abnormalities in unstable diabetics: Studies of ambulatory-fed subjects during continuous blood glucose analysis. J Clin Endocr 1972; 34: 837-46
4. Tamborlane WV, Sherwin RS, Koivisto V, Hendler R, Genel M, Felig P. Normalization of the growth hormone and catecholamine response to excercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes 1979; 28: 785-8
5. Arias P, Kerner W, de la Fuente A, Pfeiffer EF. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment. Acta Endocr 1984; 107: 250-5
6. Press M, Tamborlane WV, Thorner MO, Vale W, Rivier J, Gertner JM, Sherwin RS. Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression. Diabetes 1984; 33: 804-6
7. Lanes R, Recker B, Fort P, Lifshitz F. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 1985; 34; 156-60
8. Pietschmann P, Scherthaner G, Prsvkavec F, Gisinger CH, Freyler H. No evidence for increased growth hormone reponses to growth hormone-releasing hormone in patients wth diabetic retinopathy. Diabetes 1987; 36: 159-62
9. Cado G, Sperouy G, Dallaglio E, Valenti G, Butherini U. Non-specific GH reponse to TRH in IDDM and age-related pituitary responsiveness. J Clin Endocrinol Metab 1989; 69: 239-52
10. Asplin CM, Faria ACS, Carlsen CE, Vaccaro CM, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 239-52
11. Horner J, Kemp SF, Hintz RL. Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1981; 53: 1148-53
12. Tamborlane WV, Hintz RL, Bergmann M, Genel M, Felig P, Sherwin R. Insulin infusion pump treatment of diabetes mellitus. Influence of improved metabolic control on plasma somatomedin levels. New Engl J Med 1981; 305: 303-7
13. Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age. J Clin Endocrinol Metab 1986; 63: 651-5
14. Winter RJ, Phillips LS, Klein MN, Traisman HS, Green OC. Somatomedin activity and diabetic control in children with insulin-dependent diabetes. Diabetes 1979; 28: 952-4
15. Nash H. Growth failure, somatomedin and growth hormone levels in juvenile diabetes mellitus: a pilot study. Aust N Z J Med 1979; 9: 245-9
16. Leung DL, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: purification, cloning, and expression. Nature 1987; 330: 537-43
17. Mercado M, Molitch M, Baumann G. Low plasma growth hormone binding protein in IDDM. Diabetes 1992; 41: 605-9
18. Holl RW, Siegler B, Scherbaum WA, Heinze E. The serum growth hormone binding protein is reduced in young patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 76: 165-7
19. Masso G, Dooms L, Bouillon R, Vandershueren, Lodeweyckx M. Serum levels of growth hormone binding protein and insulin-like growth factors in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 239-43
20. Baumann G, Shaw MA, Winter RJ. Absence of plasma growth hormone binding protein in Laron type dwarfism. J Clin Endocrinol Metab 1987; 65: 814
21. Daughaday WH, Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA 1987; 84: 4636-9
22. Hardouin S, Gourmelen M, Noguiez P, Seurin P, Roghani M, Le Bouc Y, Povoa G, Merimee TJ, Hossenlopp P, Binoux M. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 1989; 69: 1291-1301
23. Camacho-Hubner C, Clemmons DR, D'Ercole AJ. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-1. Endocrinology 1991; 129: 1201-6
24. Elgin RD, Busky WHJr, Clemmons DR. An insulin-like growth factor binding protein enhances the biologic response to IGF-1. Proc Natl Acad Sci USA 1987; 84: 3254-8
25. Hintz RL, Lin F, Rosenfeld RG, Kemp SF. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab 1981; 53: 100-4
26. Zapf J, Hauri C, Waldvogel M. Recombinant human insulin-like growth factor 1 induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA 1989; 86: 3813-7
27. Meek JC, Stoskopf MM, Bolinger RE. Optimization of radioimmunoassay for human growth hormone by the charcoal-dextran technique. Clinical Chemistry 1970; 16: 845-8
28. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of Sm-C levels in normals and patients with pituitary disease by RIA. J Clin Invest 1979; 60: 648-57
29. Amit T, Barkedy RJ, Youdim MBH, Hochberg Z. A new and convenient assay of growth hormone binding protein activity in human serum. J Clin Endocrinol Metab 1990; 71: 474-9
30. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for tritation of the binding proteins and competitive binding studies. Anal Biochem 1987; 154: 138-43
31. Kaneko K, Komine S, Maeda T, Ohta M, Tsushima T, Shizume K. Growth hormone responses to growth hormone-releasing hormone and thyrotropin-releasing hormone in diabetic patients with and without retinopathy. Diabetes 1987; 34: 710-3
32. Sharp PS, Foley K, Kohner EH. Evidence for a central abnormality in the regulation of growth hormone secretion in insulin-dependent diabetes. Diabetic Med 1984; 1: 205-8
33. Jacobs ML, Lathoe HMW, Blankestijn PJ, Stijnen T, Weber RF. Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type 1 diabetes and in normal controls: effect of age, body mass index and sex. Clinical Endocrinology 1996; 44: 546-53
34. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and pituitary. Science (Wash. D.C.) 1981; 212: 1279-81
35. Morita S, Yamashita S, Melmed S. Insulin-like growth factor-I action on rat anterior pituitary cells: Effects of intracellular messengers on growth hormone secretion and messenger RNA levels. Endocrinology 1987; 121: 2000-6
36. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan A. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor-I. Involvement of hypothalamic somatostatin. J Clin Invest 1994; 94: 138-45
37. Ismail IS, Scanlon MF, Peters JR. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin-dependent diabetics: Evidence of attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Clinical Endocrinology 1993; 38: 149-57
38. Goñi MJ, Monreal M, Sopena M, Gil MJ, Moncada E, Salvador J. Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone secretion in type 1 diabetes mellitus: Further evidence supporting somatostatin's involvement in GH suppression. Metabolism 1997; 46: 1305-11
39. Spada A, Elahi FR, Arosio M, Sartorio A, Guglielmo L, Vallar L, Faglio G. Lack of desensitization of adenomatous somatotrophs to growth hormone-releasing hormone in acromegaly. J Clin Endocrinol Metab 1987; 64: 585-91
40. Press M, Caprio S, Tamborlane WV, Bhushan R, Thorner M, Vale W, Rivier J, Sherwin RS. Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes 1992; 41: 17-21
41. Martha PM, Rogol AD, Blizzard RM, Shaw MA, Baumann G. Growth hormone-binding activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab 1991; 73: 175-81
42. Fainstein Day P, Knoblovits P, Adamo G, Moses N, Gutman RA. Niveles séricos de la proteína transportadora de GH (GH-BP) en pacientes acromegálicos y en pacientes con déficit adquirido de hormona de crecimiento (GH). Congreso Panamericano de Endocrinologia. Santiago de Chile. Abstract 1994; 106:
43. Daughaday WH, Phillips LS, Mueller MD. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 1976; 98: 1214-9
44. Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 1980; 107: 1176-81
45. Roupas P, Herington AC. Cellular mechanisms in the processing of growth hormone and its receptor. Moll Cell Endocrinol 1989; 61: 1-12
46. Fratzsch J, Kellner K, Zilkern T, Schmidt-Gayk H, Selisko T, Scolz H. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus. Clinical Endocrinology 1996; 44: 673-8
47. Cortizo AM, Gagliardino JJ. Protein glycation: its role in the changes induced by diabetes in the properties of the serum insulin-like growth factor I-binding proteins. J Endocrinol 1991; 131: 33-8
48. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and IGF 1 in insulin-dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-8
49. Press M, Tamborlane W, Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. New Engl J Med 1984; 310: 810-5
50. Merimee TJ. A follow-up study of vascular disease in growth hormone-deficient dwarfs with diabetes. New Engl J Med 1978; 298: 1217-22